AASV Position Statement: Vaccine Technology
Veterinarians and swine producers use science-based decisions and outcomes to improve the health and well-being of swine. Vaccines are a critical tool for preserving and improving swine health and well-being, protecting animals from disease, keeping the food supply safe and secure, and reducing the need for antibiotics. Before use in swine in the United States, vaccines pass safety (including food safety), purity, potency, and efficacy requirements, as required by vaccine type, to successfully achieve licensure by the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB)1. Veterinary biologic products are required to have a withdrawal time. The American Association of Swine Veterinarians (AASV) supports using all vaccine technologies approved for use in swine, including but not limited to autogenous vaccines, killed vaccines, modified live vaccines, subunit vaccines, and vaccines using RNA or DNA technology. In addition, the AASV supports the research and development of new vaccine technologies and platforms to preserve and improve the health and well-being of swine, keep the food supply safe and secure, and protect swine from pain, suffering, and illness.
1USDA Center for Veterinary Biologics: https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/veterinary-biologics
Approved by the AASV Board of Directors on August 30, 2023.